PERİODONTAL HASTALIK GEÇMİŞİ OLAN HASTALARDA VE PERİODONTAL OLARAK SAĞLIKLI BİREYLERDE YAPILAN İMPLANTLARIN 29 AYLIK GERİYE DÖNÜK KLİNİK BAŞARILARININ DEĞERLENDİRİLMESİ

Yıl 2019, Cilt: 29 Sayı: 2, 197 - 205, 22.03.2019

. İşıl Damla Şener Yamaner

https://doi.org/10.17567/ataunidfd.527027

Öz

Amaç: Periodontal
hastalığa sahip bireylerde implant tedavisinin prognozu hakkında farklı
bulgulara sahip çok sayıda çalışma mevcuttur. Bu çalışmanın amacı; periodontal
hastalık geçmişi olan hastalarda ve periodontal olarak sağlıklı bireylerde ortalama
29 aylık takip süresinde implant başarısının tespiti ve implant çevre kemik
doku kaybının; sigara kullanımı, yaş, cinsiyet ve Diyabetes Mellitus (DM) gibi hastaya
bağlı parametrelere göre karşılaştırılmasıdır.

Gereç ve
Yöntem: Bu çalışmada; 14 periodontal olarak sağlıklı bireye ve 12 periodontal
hastalık geçmişi olan hastaya toplamda 139 adet implant yerleştirildi. Tüm
implantlar 8-10 hafta iyileşme sürecini takiben yüklendiler. İmplantların
çevresinde marjinal kemik kayıpları başlangıç ve ortalama 29 ay sonrasında ölçüldü.
Periodontal hastalık geçmişi olan hastalarda ve periodontal olarak sağlıklı
bireylerde implant başarısı değerlendirildi. İki hasta grubu arasında implant
çevre kemik doku kaybı hastaya bağlı parametrelere göre karşılaştırıldı.

Bulgular:
Sigara kullanımı ve DM; implant çevresi marginal kemik kaybını her iki hasta
grubunda istatistiksel olarak anlamlı şekilde etkilemiştir (p≤ 0,05). Periodontal
hastalığa sahip bireyler grubunda kadın hastalarda marjinal kemik kaybı
değerleri erkek hastalara kıyasla daha düşüktür. Buna karşılık sağlıklı
bireyler grubunda; kadın hastalarda takip süresi içerisindeki ortalama kemik
kaybı erkek hastalardan daha fazladır. Ancak her iki gruptaki bu farklılık
istatistiksel olarak anlamlı bulunmamıştır (p≥ 0,05). Takip süresi içerisindeki
ortalama kemik kaybı değerleri her iki grup içinde genç bireylerde, orta ve
yaşlı bireylere göre daha az bulunmuştur. Ancak bu farklılık istatistiksel
olarak anlamlılık ifade etmemiştir (p≥ 0,05). Çalışmada 29 aylık ortalama
başarı oranı tüm implantlarda, Periodontal hastalığa sahip bireylerde ve Periodontal
olarak sağlıklı bireyler gruplarında sırasıyla; %95, %93,8 ve %96,6 olarak
tespit edilmiştir.

Sonuç:
İmplantların takip süresi içerisindeki marjinal kemik kayıplarına diabet ve
sigara kullanımının etkisi açıktır. Çevre marjinal kemik kayıpları periodontal
hastalık geçmişi olan bireylerde, periodontal olarak sağlıklı bireylere göre
istatistiksel olarak anlamlı artış göstermiştir. Bu açıdan periodontal hastalık
geçmişi olan bireylerde implant tedavisinde ikincil başarısızlık faktörlerinin
dikkatli değerlendirilmesi gerekmektedir.

Anahtar
Kelimeler: Periodontitis, Dental İmplant, Diabet

THE SUCCESS RATES OF IMPLANTS IN PERIODONTALLY COMPROMISED AND
PERIODONTALLY HEALTHY PATIENTS- A 29 MONTHS RETROSPECTIVE EVALUATION

ABSTRACT

Aim: The aim of this study is the evaluation of the success rate of
implants in periodontally compromised and periodontally healthy patients in
average 29 months follow-up time. And comparison of the marginal bone loss
around implants according to patient related parameters as smoking, age, gender
and diabetes mellitus.

Materials and Methods: One hundred and thirty nine implants were
placed in 14 periodontally healthy and 12 periodontally compromised patients
and loaded with final restorations 8-10 weeks of healing time. Marginal bone
loss around implants was determined radiographically at initial and after a
mean observation time average of 29 months. The smoking habit, Diabetes
Mellitus, age and gender on the marginal bone loss was evaluated.

Results: Marginal bone loss was affected statistically
significantly by smoking and DM, in both groups (p≤ 0,05). In PHB group
marginal bone loss was found higher for men, in PSB group marginal bone loss
was found higher for women but for both of the groups these differences were
not statistically significant (p≥ 0,05). Also in both of the groups age was not
the decisive factor for marginal bone loss. The overall cumulative survival
rate for 29 months was % 95 and for PHB and PSB groups consecutively, %93,8,
%96,6.

Conclusion:  The affect of
smoking and DM is obvious for the marginal bone loss for both of the groups.
And for periodontally compromised patients bone loss increases statistically
significantly higher in comparison to healthy patients. During the implant
treatment, for periodontally compromised patients secondary factors must be
followed carefully.

Key words: Periodontitis, Dental Implant, Diabetes Mellitus

Anahtar Kelimeler

Periodontitis, Dental İmplant

Kaynakça

• 1.Ong CTT, Ivanovski S, Needleman IG, Retzepi M, Moles DR, Tonetti MS, Donos N. Systematic review of implant outcomes in treated periodontitis subjects. J Clin Periodontol 2008; 35: 438–62.
• 2.Renvert S,Persson GR. Periodontitis as a potential risk factor for peri-implantitis. J Clin Periodontol 2009; 36 (Suppl.10): 9–14.
• 3.Karoussis IK, Salvi GE, Heitz-Mayfield LJ, Bragger U, Hammerle CH, Lang NP. Long-term implant prognosis in patientswith and without a history of chronic periodontitis: a 10-year prospective cohort study of the ITI Dental Implant system. Clin Oral Implants Res2003; 14: 329–39.
• 4.Mengel R, Behle M, Flores de Jacoby L. Osseointegrated implants in subjects treated for generalized aggressive periodontitis: 10-year results of a prospective, long-term cohort study. J Periodontol 2007; 78: 2229–37.
• 5.Mengel R, Flores-de-Jacoby L. Implants in patients treated for generalized aggressive and chronic periodontitis: a 3-year prospective longitudinal study. J Periodontol 2005; 76: 534– 43.
• 6.Aloufi F, Bissada N, Ficara A, Faddoul F, Al- Zahrani MS. Clinical assessment of periimplant tissues in patients with varying severity of chronic periodontitis. Clin Implant Dent Relat Res 2009; 11: 37–40.
• 7. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: A two-way relationship. Ann Periodontol 1998; 3: 51–61.
• 8. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014; 103(2): 137-49.
• 9. Almas K, Al-Qahtani M, Al-Yami M, Khan N. The relationship between periodontal disease and blood glucose levelamong type II diabetic patients. J Contemp Dent Pract 2001; 2(4): 18-25.
• 10. Liu R, Bal HS, Desta T, Krothapalli N, Alyassi M, Luan Q et al. Diabetes enhances periodontal bone loss through enhanced resorption and diminished bone formation. J Dent Res 2006; 85(6): 510-4.
• 11. Tsai C, Hayes C, Taylor GW. Glycemic control of type 2 diabetes and severe periodontal disease in the US adult population. Community Dent Oral Epidemiol 2002; 30: 182-92.
• 12. Singhal S, Pradeep AR, Kanoriya D, Garg V. Human soluble receptor for advanced glycation end products and tumor necrosis factor-α as gingival crevicular fluid and serum markers of inflammation in chronic periodontitis and type 2 diabetes. J Oral Sci 2016; 58(4): 547-53.
• 13. Chang PC, Chien LY, Yeo JF, Wang YP, Chung MC, Chong LY et al. Progression of periodontal destruction and the roles of advanced glycation end products in experimental diabetes. J Periodontol. 2013; 84(3): 379-88.
• 14. Abduljabbar T, Al-Sahaly F, Al-Kathami M, Afzal S, Vohra F. Comparison of periodontal and periimplant inflammatory parameters among patients with prediabetes, type 2 diabetes mellitus and non-diabetic controls. Acta Odontol Scand 2017; 75(5): 319-24.
• 15. Al Amri MD, Abduljabbar TS, Al-Kheraif AA, Romanos GE, Javed F. Comparison of clinical and radiographic status around dental implants placed in patients with and without prediabetes: 1-year follow-up outcomes. Clin Oral Implants Res 2017; 28(2): 231-5.
• 16. U.S. Department of Health and Human Services. The health consequences of smoking: a report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services. Office on Smoking and Health, 2004.
• 17. Mallampalli A, Guntupalli KK. Smoking and systemic disease. Clin Occup Environ Med 2006; (5): 173–92.
• 18. Winn DM. Tobacco use and oral disease. J Dent Educ 2001; 65: 306–12.
• 19. Axelsson P, Paulander J, Lindhe J. Relationship between smoking and dental status in 35-, 50-, 65-, and 75-year-old individuals. J Clin Periodontol 1998; (25): 297–305.
• 20. Van der Velden U, Varoufaki A, Hutter JW, Xu L, Timmerman MF, Van Winkelhoff AJ, Loos BG. Effect of smoking and periodontal treatment on the subgingival microflora. J Clin Periodontol. 2003; 30: 603–10.
• 21. Genco RJ, Borgnakke WS: Risk factors for periodontal disease. Periodontol 2000 2013; 62(1): 59-94.
• 22. Matarasso S, Rasperini G, Iorio Siciliano V, Salvi GE, Lang NP, Aglietta M: A 10-year retrospective analysis of radiographic bone-level changes of implants supporting single-unit crowns in periodontally compromised vs. periodontally healthy patients. Clin Oral Implants Res 2010; 21: 898-903.
• 23. Mengel R, Schroder T, Flores-de-Jacoby L: Osseointegrated implants in patients treated for generalized chronic periodontitis and generalized aggressive periodontitis: 3- and 5-year results of a prospective long-term study. J Periodontol 2001; 72: 977-89.
• 24. Klokkevold PR, Han TJ: How do smoking, diabetes, and periodontitis affect outcomes of implant treatment? Int J Oral Maxillofac Implants 2007; 22 Suppl:173-202.
• 25. Jiang BQ, Lan J, Huang HY, Liang J, Ma XN, Huo LD, Xu X: A clinical study on the effectiveness of implant supported dental restoration in patients with chronic periodontal diseases. Int J Oral Maxillofac Surg 2013; 42: 256-9.
• 26. Eick S, Ramseier CA, Rothenberger K, Brägger U, Buser D, Salvi GE. Microbiota at teeth and implants in partially edentulous patients. A 10-year retrospective study. Clin Oral Implants Res. 2016; 27(2): 218-25.
• 27. Lee DW. Periodontitis and dental implant loss. Evid Based Dent 2014; 15: 59-60.
• 28. Ramanauskaite A, Baseviciene N, Wang HL, Tözüm TF. Effect of history of periodontitis on implant success: meta-analysis and systematic review. Implant Dent 2014; 23: 687-96
• 29. Hardt CRE, Grondahl K, Lekholm U, Wennstrom JL. Outcome of implant therapy in relation to experienced loss of periodontal bone support -a retrospective 5-year study. Clini Oral Implants Res 2002; 13: 488–94.
• 30. Armitage GC. Development of a classification systems for periodontal diseases and conditions. Ann Periodontol 1999; 4: 1-6.
• 31. Galindo-Moreno P, Leon-Cano A, Monje A, et al. Abutment height influences the effect of platform switching on periimplant marginal bone loss. Clin Oral Implants Res. 2016; 27: 167–73.
• 32. Buser D, von Arx T, ten Bruggenkate C, et al. Basic surgical principles with ITI implants. Clin Oral Implants Res 2000; 11(suppl 1): 59–68.
• 33. Hopp M, de Araújo Nobre M, Maló P. Comparison of marginal bone loss and implant success between axial and tilted implants in maxillary All-on-4 treatment concept rehabilitations after 5 years of follow-up. Clin Implant Dent Relat Res 2017; 19(5): 849-59.
• 34. Monje A, Aranda L, Diaz KT, Alarcón MA, Bagramian RA, Wang HL, Catena A. Impact of Maintenance Therapy for the Prevention of Peri-implant Diseases: A Systematic Review and Meta-analysis. J Dent Res 2016; 95(4): 372-9.
• 35. Rosenquist B, Grenthe B. Immediate placement of implants into extraction sockets: implant survival. International J Oral Maxillofac Implants 1996; 11: 205–9.
• 36. Anner R, Grossmann Y, Anner Y, Levin L. Smoking, diabetes mellitus, periodontitis, and supportive periodontal treatment as factors associated with dental implant survival: a long-term retrospective evaluation of patients followed for up to 10 years. Implant Dent 2010; 19:57–64.
• 37. Fardal O, Linden GJ. Tooth loss and implant outcomes in patients refractory to treatment in a periodontal practice. J Clin Periodontol 2008; 35: 733–8.
• 38. Simonis P, Dufour T, Tenenbaum H. Long-term implant survival and success: a 10–16-year follow-up of nonsubmerged dental implants. Clin Oral Implants Res 2010; 21: 772–7.
• 39. Aglietta M, Siciliano VI, Rasperini G, Cafiero C, Lang NP, Salvi GE. A 10-year retrospective analysis of marginal bone-level changes around implants in periodontally healthy and periodontally compromised tobacco smokers. Clin Oral Implants Res 2011; 22: 47–53.
• 40. Gatti C, Gatti F, Chiapasco M, Esposito M. Outcome of dental implants in partially edentulous patients with and without a history of periodontitis: a 5-year interim analysis of a cohort study. European J Oral Implantol 2008; 1: 45–51.
• 41. Roccuzzo M, Bonino F, Aglietta M, Dalmasso P. Ten-year results of a three arms prospective cohort study on implants in periodontally compromised patients. Part 2: clinical results. Clin Oral Implants Res 2012; 23: 389–95.
• 42. Al Zahrani, Al Mutairi AA. Stability and bone loss around submerged and non-submerged implants in diabetic and non-diabetic patients: a 7-year follow-up. Braz Oral Res 2018;10:32:e57.
• 43. Koldsland OC, Scheie AA, Ass AM. Prevalence of implant loss and the influence of associated factors. J Periodontol 2009; 80: 1069–75.
• 44. de Araújo Nobre M, Maló P, Gonçalves Y, Sabas A, Salvado F. Dental implants in diabetic patients: retrospective cohort study reporting on implant survival and risk indicators for excessive marginal bone loss at 5 years. J Oral Rehabil 2016; 43:863–70.
• 45. Chrcanovic BR, Albrektsson T, Wennerberg A. Diabetes and oral implant failure: a systematic review. J Dent Res 2014; 93: 859–67.
• 46. Hämmerle CHF, Cordaro L, Alccayhuaman KAA, Botticelli D, Esposito M, Colomina LE, Gil A, Gulje FL, Ioannidis A, Meijer H, Papageorgiou S, Raghoebar G, Romeo E, Renouard F, Storelli S, Torsello F, Wachtel H. Biomechanical aspects: Summary and consensus statements of group 4. The 5th EAO Consensus Conference 2018. Clin Oral Implants Res. 2018; 29 Suppl 18: 326-31.